Meysam Ebrahimifar
- Co-authors
- Hasan Ebrahimi ShahmabadiMahshid MohammadianAzim AkbarzadehHemen Moradi‐SardarehHadi Zare‐ZardiniAndrej JenčaAmir Nili‐AhmadabadiAlireza Mosavi-Jarrahi
- Topics
- Nanoparticle-Based Drug Delivery (7 papers)Bioactive Compounds and Antitumor Agents (2 papers)RNA Interference and Gene Delivery (2 papers)
- Partner nations
- IranSlovakiaUnited States
In The Last Decade
Meysam Ebrahimifar
18 papers receiving 313 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 115
- Biomaterials 109
- Oncology 63
- Biomedical Engineering 58
- Molecular Medicine 46
Countries citing papers authored by Meysam Ebrahimifar
This map shows the geographic impact of Meysam Ebrahimifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meysam Ebrahimifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meysam Ebrahimifar more than expected).
Fields of papers citing papers by Meysam Ebrahimifar
This network shows the impact of papers produced by Meysam Ebrahimifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meysam Ebrahimifar. The network helps show where Meysam Ebrahimifar may publish in the future.
Co-authorship network of co-authors of Meysam Ebrahimifar
This figure shows the co-authorship network connecting the top 25 collaborators of Meysam Ebrahimifar. A scholar is included among the top collaborators of Meysam Ebrahimifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meysam Ebrahimifar. Meysam Ebrahimifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 28 | |
| 5 | 10 | |
| 6 | 10 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 24 | |
| 10 | 18 | |
| 11 | 15 | |
| 12 | 33 | |
| 13 | 43 | |
| 14 | 18 | |
| 15 | 13 | |
| 16 | 39 | |
| 17 | 25 | |
| 18 | 30 |
About Meysam Ebrahimifar
Meysam Ebrahimifar is a scholar working on Biomaterials, Toxicology and Applied Microbiology and Biotechnology, having authored 18 papers that have together received 316 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Bioactive Compounds and Antitumor Agents (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Molecular Medicine (46 citations), Biomaterials (109 citations) and Pharmaceutical Science (29 citations). Meysam Ebrahimifar has collaborated with scholars based in Iran, Slovakia and United States. Frequent co-authors include Hasan Ebrahimi Shahmabadi, Mahshid Mohammadian, Azim Akbarzadeh, Azim Akbarzadeh, Hemen Moradi‐Sardareh, Hadi Zare‐Zardini, Andrej Jenča, Amir Nili‐Ahmadabadi, Alireza Mosavi-Jarrahi and Zahra Saffari. Their work appears in journals such as Applied Sciences, Pharmaceutics and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.